Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, David J. Sullivan, Andrew Pekosz, Fabrizio Maggi, Arturo Casadevall
{"title":"下一次流感大流行的被动免疫疗法","authors":"Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, David J. Sullivan, Andrew Pekosz, Fabrizio Maggi, Arturo Casadevall","doi":"10.1002/rmv.2533","DOIUrl":null,"url":null,"abstract":"Influenzavirus is among the most relevant candidates for a next pandemic. We review here the phylogeny of former influenza pandemics, and discuss candidate lineages. After briefly reviewing the other existing antiviral options, we discuss in detail the evidences supporting the efficacy of passive immunotherapies against influenzavirus, with a focus on convalescent plasma.","PeriodicalId":21180,"journal":{"name":"Reviews in Medical Virology","volume":"75 1","pages":""},"PeriodicalIF":9.0000,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Passive immunotherapies for the next influenza pandemic\",\"authors\":\"Daniele Focosi, Massimo Franchini, Jonathon W. Senefeld, Michael J. Joyner, David J. Sullivan, Andrew Pekosz, Fabrizio Maggi, Arturo Casadevall\",\"doi\":\"10.1002/rmv.2533\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Influenzavirus is among the most relevant candidates for a next pandemic. We review here the phylogeny of former influenza pandemics, and discuss candidate lineages. After briefly reviewing the other existing antiviral options, we discuss in detail the evidences supporting the efficacy of passive immunotherapies against influenzavirus, with a focus on convalescent plasma.\",\"PeriodicalId\":21180,\"journal\":{\"name\":\"Reviews in Medical Virology\",\"volume\":\"75 1\",\"pages\":\"\"},\"PeriodicalIF\":9.0000,\"publicationDate\":\"2024-04-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reviews in Medical Virology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/rmv.2533\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"VIROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in Medical Virology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/rmv.2533","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"VIROLOGY","Score":null,"Total":0}
Passive immunotherapies for the next influenza pandemic
Influenzavirus is among the most relevant candidates for a next pandemic. We review here the phylogeny of former influenza pandemics, and discuss candidate lineages. After briefly reviewing the other existing antiviral options, we discuss in detail the evidences supporting the efficacy of passive immunotherapies against influenzavirus, with a focus on convalescent plasma.
期刊介绍:
Reviews in Medical Virology aims to provide articles reviewing conceptual or technological advances in diverse areas of virology. The journal covers topics such as molecular biology, cell biology, replication, pathogenesis, immunology, immunization, epidemiology, diagnosis, treatment of viruses of medical importance, and COVID-19 research. The journal has an Impact Factor of 6.989 for the year 2020.
The readership of the journal includes clinicians, virologists, medical microbiologists, molecular biologists, infectious disease specialists, and immunologists. Reviews in Medical Virology is indexed and abstracted in databases such as CABI, Abstracts in Anthropology, ProQuest, Embase, MEDLINE/PubMed, ProQuest Central K-494, SCOPUS, and Web of Science et,al.